7
6
↑7
↓6
—0
Evidence suggests Walking mayincreaseMortality.
7 studies (13 claims)
Emerging evidence
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| walking time of ≥150 min/week | Decreases - were associated with a reduced risk | mortality | Human | patients with idiopathic pulmonary fibrosis (IPF) | Walking times of <100 min/week, 100 to <150 min/week, and ≥150 min/week. | Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis.cited 10× |
| walking time of 100 to <150 min/week | Decreases - were associated with a reduced risk | mortality | Human | patients with idiopathic pulmonary fibrosis (IPF) | Walking times of <100 min/week, 100 to <150 min/week, and ≥150 min/week. | Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis.cited 10× |
| combination of shorter sitting and extended walking times | Decreases - was further reduced | risk for mortality | Human | patients with idiopathic pulmonary fibrosis (IPF) | Walking times of <100 min/week, 100 to <150 min/week, and ≥150 min/week. | Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis.cited 10× |
| longer weekly walking times | Decreases - were associated with reduced | hospitalization and mortality risks | Human | patients with idiopathic pulmonary fibrosis (IPF) | Walking times of <100 min/week, 100 to <150 min/week, and ≥150 min/week. | Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis.cited 10× |
| slow walking speed | Increases - association with | 1-year adjusted mortality risk | Human | frail patients | Not specified | Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.cited 248× |
| Regular walking | Decreases - associated with reduced | all-cause and cardiovascular disease mortality | Human | — | Not specified | Physical activity and exercise health benefits: cancer prevention, interception, and survival.cited 11× |
| 6-minute walking test (6MWT) | Decreases - predicted | all-cause mortality | Human | HF patients | Not specified | Pre-Discharge Evaluation in Heart Failure – Additive Predictive Value of the 6-Minute Walking Test to Clinical Scores.cited 8× |
| 6-minute walking test (6MWT) | Increases - is an independent predictor of | all-cause mortality | Human | asymptomatic patients with aortic valve stenosis | Not applicable (6MWT performance assessed, not a dosage). | Six-minute walking test and long term prognosis in patients with asymptomatic aortic valve stenosis.cited 5× |
| 6-minute walking test (6MWT) | Increases - is an independent predictor of | cardiovascular mortality | Human | asymptomatic patients with aortic valve stenosis | Not applicable (6MWT performance assessed, not a dosage). | Six-minute walking test and long term prognosis in patients with asymptomatic aortic valve stenosis.cited 5× |
| 6-Minute Walking Test (6MWT) | Increases - significant predictor of mortality | mortality | Human | community-dwelling older men and women | Not specified (physical performance tests were measured, not administered as interventions). | A Comparison of Objective Physical Performance Tests and Future Mortality in the Elderly People.cited 65× |
| 6-Minute Walking Test (6MWT) | Increases - highest C-index | mortality | Human | men | Not specified (physical performance tests were measured, not administered as interventions). | A Comparison of Objective Physical Performance Tests and Future Mortality in the Elderly People.cited 65× |
| walking speed (WS) | Increases - showed the best accuracy | 3-year mortality | Human | people aged 60+ | Not specified | Comparing the prognostic value of geriatric health indicators: a population-based study.cited 33× |
| walking speed (WS) | Increases - showed the best accuracy | 5-year mortality | Human | people aged 60+ | Not specified | Comparing the prognostic value of geriatric health indicators: a population-based study.cited 33× |